1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 21 MARCH 2016

Cancer Drug News 21 MARCH 2016

  • March 2016
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Fast-Paced Treatment Optimisation Will Continue To Drive Up Cancer Drug Spend
Industry Brief - Allergan Confirms Paclitaxel Patent Challenge
Industry Trend Analysis - Academia To Benefit From Increasing Value Placed On Innovation
Industry Brief - Ono Seeks Additional Indication For Opdivo In Japan
Industry Brief - Vyxeos Phase III AML Study Meets Primary Endpoint
Industry Brief - Spectrum Gains FDA Approval For Evomela
Industry Brief - Enrolment Completed In Vx-001 Phase IIb NSCLC Trial
Industry Brief - FDA Grants Priority Review For Atezolizumab In Advanced UC
Industry Brief - HMP Begins Sulfatinib Phase III Pancreatic NET Trial In China
Industry Brief - First Patient Dosed In Halozyme's Halo-301 Phase III MPC Trial
Industry Brief - Immunomedics Stops Phase III PANCRIT-1 Trial In Advanced Pancreatic Cancer
Industry Brief - DelMar's VAL-083 Receives FDA ODD For Medulloblastoma
Industry Brief - BioInvent/Oncurious Partner NMTRC To Accelerate TB-403 Phase I/IIa Trial
Industry Trend Analysis - Innovation And Differentiation Will Drive Change For GSK
Industry Trend Analysis - Roche Willing To Pay Out For Innovation
Industry Brief - Tesaro Files Rolapitant IV NDA In US
Industry Brief - Ono Gains Approval For Partial Change In Proemend Labelling
Industry Brief - Onxeo Establishes US Subsidiary
Industry Brief - Cancer Conferences - June 2016

Table Of Contents

Cancer Drug News 21 MARCH 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.